Literature DB >> 23143060

Circulating monocytes are not the major source of plasma cytokines in patients with sepsis.

Patrik Gille-Johnson1, Christian Smedman, Lindvi Gudmundsdotter, Anna Somell, Kopek Nihlmark, Staffan Paulie, Jan Andersson, Bengt Gårdlund.   

Abstract

In sepsis, large quantities of inflammatory cytokines are released into the bloodstream. The cellular source of these cytokines is unclear, and we have here investigated to what extent circulating cells in blood contributed to this production. We used the enzyme-linked immunospot technique to study the spontaneous as well as the lipopolysaccharide (LPS)-induced secretion of the proinflammatory cytokines interleukin 6 (IL-6), tumor necrosis factor α (TNF-α), granulocyte-macrophage colony-stimulating factor, IL-1β, IL-12p40, and the anti-inflammatory cytokine IL-10 from whole-blood cells. The study comprised 32 septic patients (24 with septic shock) and 30 healthy controls. Despite significantly increased plasma cytokine levels in the septic patients, the number of spontaneous cytokine-secreting cells was small or nonexistent and did not differ between the two groups. Lipopolysaccharide stimulation of cells from the same samples triggered substantially increased numbers of cytokine-producing cells in both patients and controls. However, although the numbers of IL-6- and tumor necrosis factor α-secreting monocytes were very similar in both groups, significantly fewer IL-1β-, IL-10-, IL-12p40-, and granulocyte-macrophage colony-stimulating factor-secreting monocytes were seen in samples from septic patients as compared with healthy controls. The reduced number of cytokine-secreting cells in response to LPS stimulation correlated with disease severity, as expressed by Sequential Organ Failure Assessment score and the stage of sepsis. In summary, circulating leukocytes did not appear to be responsible for the increased plasma levels of cytokines observed in sepsis. A selective sepsis-induced downregulation of cytokine secretion in response to LPS underscores the complexity of cytokine regulation in sepsis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23143060     DOI: 10.1097/SHK.0b013e3182746e52

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  Alternative pre-mRNA splicing of Toll-like receptor signaling components in peripheral blood mononuclear cells from patients with ARDS.

Authors:  Rachel Z Blumhagen; Brenna R Hedin; Kenneth C Malcolm; Ellen L Burnham; Marc Moss; Edward Abraham; Tristan J Huie; Jerry A Nick; Tasha E Fingerlin; Scott Alper
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-03       Impact factor: 5.464

2.  Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA-146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression.

Authors:  Ming Gao; Xiaohui Wang; Xia Zhang; Tuanzhu Ha; He Ma; Li Liu; John H Kalbfleisch; Xiang Gao; Race L Kao; David L Williams; Chuanfu Li
Journal:  J Immunol       Date:  2015-06-05       Impact factor: 5.422

3.  Attenuation of Sepsis-Induced Cardiomyopathy by Regulation of MicroRNA-23b Is Mediated Through Targeting of MyD88-Mediated NF-κB Activation.

Authors:  Chao Cao; Yan Zhang; Yanfen Chai; Lijun Wang; Chengfen Yin; Songtao Shou; Heng Jin
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 4.  Defects in innate and adaptive immunity in patients with sepsis and health care associated infection.

Authors:  Thomas Ryan; John D Coakley; Ignacio Martin-Loeches
Journal:  Ann Transl Med       Date:  2017-11

5.  Evaluating the effects of protective ventilation on organ-specific cytokine production in porcine experimental postoperative sepsis.

Authors:  Jesper Sperber; Miklós Lipcsey; Anders Larsson; Anders Larsson; Jan Sjölin; Markus Castegren
Journal:  BMC Pulm Med       Date:  2015-05-10       Impact factor: 3.317

6.  Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID-19.

Authors:  Robin Kahn; Tobias Schmidt; Karan Golestani; Anki Mossberg; Birgitta Gullstrand; Anders A Bengtsson; Fredrik Kahn
Journal:  J Leukoc Biol       Date:  2020-08-13       Impact factor: 6.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.